One-electron reductases that reduce nitro compounds in hypoxic human tumour cells are poorly characterized, but are important for targeting hypoxia with nitroaromatic prodrugs. Fluorogenic probes with defined reductase profiles are needed to interrogate the activity of these enzymes in intact cells. In the present paper, we report a 6-nitroquinolone ester (FSL-61) as a fluorogenic probe for POR (NADPH:cytochrome P450 oxidoreductase) activity under hypoxia, and demonstrate its suitability of monitoring POR by flow cytometry. Reduction of FSL-61 by purified recombinant human POR generated the corresponding hydroxylamine, which was non-fluorescent, but was reduced further to the fluorescent amine in cells. Hydrolysis of the ester side chain facilitated cellular entrapment, enabling detection of heterogeneous POR expression in mixed populations of cells. In addition to POR, forced expression of three other diflavin reductases [MTRR (methionine synthase reductase), NDOR1 (NADPH-dependent diflavin oxidoreductase 1) and NOS2A (nitric oxide synthase 2A)] or NADPH:adrenoredoxin oxidoreductase in HCT116 cells significantly increased hypoxic activation of FSL-61. This reductase profile is similar to that for the dinitrobenzamide prodrug PR-104A under hypoxia, and fluorogenic metabolism of FSL-61 correlated significantly with PR-104A activation in a panel of 22 human tumour cell lines. The present study thus demonstrates the utility of FSL-61 for rapid and non-destructive interrogation of the activity of one-electron reductases in hypoxic cells at the single-cell level.
INTRODUCTION
Hypoxia is an important driver of multiple overlapping aspects of tumour progression and also contributes to therapeutic resistance to radiotherapy and some chemotherapy drugs [1] [2] [3] . This has elicited much interest in the development of bioreductive prodrugs for killing hypoxic cells [3, 4] , and development of diagnostic probes for detecting hypoxia in tumours [5] . The latter include fluorogenic probes that generate fluorescent metabolites via enzymatic reduction in hypoxic cells [6] [7] [8] [9] [10] [11] [12] [13] . This approach has been most thoroughly studied for nitroaromatic compounds in which the fluorescence-quenching electron-withdrawing nitro group can be reduced by one-electron reductases, via a nitro radical, to an electron-donating hydroxylamine or amine with high fluorescence quantum yield, whereas the nitro radical intermediate is reoxidized to the parent compound by oxygen to suppress fluorescence in oxic cells [14] . Notably, this same biochemistry is the basis for the hypoxia-selective cytotoxicity of nitroaromatic prodrugs, including agents currently in clinical trial such as the dinitrobenzamide mustard PR-104 [15, 16] and the 2-nitroimidazole mustard TH-302 [17, 18] .
The utility of bioreductive prodrugs for targeting hypoxia depends not only on the presence of hypoxia, but also on the activity of one-electron reductases in those cells. It is reasonable to expect that close chemical and mechanistic match between a fluorogenic probe and its cognate bioreductive prodrug will make it more likely that both are activated by the same reductases, and thus that the probe can interrogate reductase activity as well as hypoxia. However, the one-electron reductases in human tumour cells are poorly characterized. The diflavin reductase POR (NADPH:cytochrome P450 oxidoreductase) is considered to be a major contributor [16, 19] , but other flavoproteins have been shown to be capable of catalysing one-electron reduction of nitro compounds, including MTRR (methionine synthase reductase), NDOR1 (NADPH-dependent diflavin oxidoreductase 1) [16] , NOS (nitric oxide synthase) isoforms NOS1, NOS2A and NOS2B [20, 21] , thioredoxin reductase [22] , CYB5R3 (NADHdependent cytochrome b 5 reductase 3) [23] , aldehyde oxidase [24, 25] and xanthine oxidase [26, 27] . However, there is little information on the contribution that these or other enzymes make, at physiological levels of expression, to bioreductive prodrug activation in tumours.
In the present study, we have identified a novel fluorogenic probe for the one-electron reductase activity of human POR in hypoxic cells. The approach taken was to evaluate nitroaromatic compounds previously screened as probes for bacterial twoelectron (oxygen-insensitive) nitroreductases, and as hypoxiaselective fluorogenic probes in a POR-overexpressing MDA-MB-231 cell line [28, 29] . An important objective was to identify a probe providing a fluorescent metabolite that is retained well enough in cells to detect heterogeneity of POR activity by flow cytometry. We characterize the bioreductive metabolism of the most promising of these probes, the 6-nitroquinolone ester FSL-61, and demonstrate that it is also a substrate for other one-electron reductases known to activate bioreductive prodrugs of current interest for targeting tumour hypoxia. 
EXPERIMENTAL

Compounds and chemical or enzymatic reduction
The fluorogenic probe compounds ( Figure 1A ) were synthesized at the Auckland Cancer Society Research Centre as reported previously [29] , and stock solutions in DMSO were stored at − 80
• C. Chemical reduction of FSL-61 {methyl 2-[6-nitro-4-oxoquinolin-1(4H)-yl]acetate; 99 % purity by HPLC} and the corresponding acid {2- [6-nitro-4-oxoquinolin-1(4H) yl]acetic acid; compound 4} was achieved by zinc dust reduction in a 5 % H 2 /Pd catalyst anaerobic chamber (Coy Instruments). The reaction was initiated by addition of ammonium acetate (30 mg) into the FSL-61 solution (7 mg/ml in acetonitrile) followed by 30 mg of zinc powder. After mixing by inversion for 5 min, the reaction was terminated by centrifugation at 220 g for 5 min, and the supernatant was stored immediately at − 80
• C. Enzymatic reduction of FSL-61 was conducted under anoxic conditions in the same anaerobic chamber. Human recombinant POR (5.3 μg, 20-55 units/mg, Abcam), 1 mM FSL-61 and 5 mM NADPH in 100 μl of 0.3 M phosphate buffer (13.6 g/l KH 2 PO 4 and 17.4 g/l K 2 HPO 4 , pH7.6) was incubated for 1 h at room temperature (22
• C). The reaction was terminated by freezing at − 80 • C. Samples were diluted 100-fold (chemical reduction) or 10-fold (enzymatic reduction) in mobile phase for analysis by HPLC and LC (liquid chromatography)-MS.
Cell culture
The origins of the cell lines used in the present study have been reported previously [30] . Cell lines were passaged in culture in αMEM (α minimal essential medium) with 5 % (v/v) FBS (fetal bovine serum) without antibiotics for <3 months from frozen stocks confirmed to be Mycoplasma-free by PCR-ELISA (Roche 2)} and confirmation of expression using an inducible V5 tag has been reported previously [16, 30] . The transfected cell lines were grown in 5 % (v/v) FBS with 3 μM puromycin.
Flow cytometry and confocal microscopy
A total of 10 6 cells were seeded in non-tissue-culture-treated 24-well plates (BD Biosciences) in 500 μl of Phenol Red-free αMEM with 5 % (v/v) FBS and incubated with the fluorogenic probes at 37
• C under oxic and anoxic conditions for up to 3 h. Anoxic incubations were performed in an anaerobic chamber as above, using medium and plasticware equilibrated in the chamber for at least 3 days. The cells were taken into the anoxic chamber in a centrifuged cell pellet (220 g for 5 min) which was resuspended to 2×10 6 cells/ml. The contents of each well were then collected and stored in the dark on ice and analysed by flow cytometry within 2 h, using a BD LSRII flow cytometer with BD FACSDiva software (Becton Dickson). The excitation wavelength was 355 nm, with emission at 425-475 nm for FSL-41, FSL-61 and FSL-76 and 515-545 nm for FSL-95. Single cells were gated using forward-and side-scatter with a 488 nm laser. For confocal microscopy, 10 6 cells were seeded in tissue culture 35-mm-diameter Petri dishes (BD Biosciences) in the above medium. After 2 h, FSL-61 was added, and cells were imaged with a Leica TCS SP2 confocal microscope after incubating for 3 h under oxic and anoxic conditions.
Metabolite analysis by HPLC
Cells were seeded in 24-well plates (10 6 cells/well) as for flow cytometry, incubated with FSL-61 (300 μM) at 37
• C under oxic and anoxic conditions for 0.5 and 3 h, collected by centrifugation, and the cell pellet was then resuspended in 10 μl of water followed by addition of 50 μl of ice-cold acetonitrile which was added dropwise while vortex-mixing. A sample of the supernatant was processed similarly (20 μl of supernatant mixed with 10 μl of water, then 50 μl of acetonitrile). The samples were stored in glass vials at − 80
• C, and analysed subsequently by HPLC with photodiode array absorbance and fluorescence detectors (Agilent Technologies 1100 LC). Retention times were corrected for the offset between detectors. The samples were diluted 1:2 with mobile phase (0.01 % formic acid in water) and 10 μl was injected for separation on a Zorbax SB-C 18 capillary column (3.0 mm×150 mm, 5 μm; Agilent Technologies) at 45
• C with a flow rate of 0.5 ml/min. The mobile phase was a linear gradient of acetonitrile (10-50 % over 25 min) in 0.01 % formic acid in water. Absorbance spectra (230-900 nm) were collected. Fluorescence excitation was at 280 nm and emission was monitored at 460 nm. Mass spectra were collected using an Agilent 6150 LC-MS instrument with ESI (electrospray ionization) using alternating positive and negative ionization. The m/z ratio was scanned from 100 to 800 with a fragmentation voltage of 135 V. FSL-61 and its corresponding nitro-acid (compound 4) were quantified against standard curves using UV absorbance peak areas. Concentrations of FSL-61 metabolites were estimated by MS, using FSL-61 and compound 4 standard curves, assuming that detection efficiency of compounds 1 and 2 is the same as for FSL-61 and compound 3 is the same as compound 4.
Oxidoreductase screen
Each of the reductase-overexpressing HCT116 lines, as described above, were seeded in 24-well plates as for flow cytometry. The flavoprotein inhibitor DPI (diphenyleneiodonium chloride) (Sigma-Aldrich) was added to a final concentration of 100 μM, or an equal volume of culture medium was added to controls. After incubation for 1 h at 37
• C under oxic or anoxic conditions (as above), FSL-61 was added to 300 μM and, 3 h later, cells were harvested for flow cytometry, as above.
RESULTS
FSL-61 is a hypoxia-selective POR-activated fluorogenic probe
Previous fluorescent plate reader screens have identified several nitroaromatic compounds providing hypoxia-dependent fluorescence in MDA-MB-231 cells that overexpress POR [28, 29] . From these screens, we selected four compounds (6-nitroquinolones FSL-41 and FSL-61, 2-nitroacridone FSL-76 and 6-nitroquinazoline FSL-95; Figure 1A ) with the highest hypoxic selectivity and greatest differential activation in the POR-overexpressing line. The suitability of these compounds for evaluating POR activity by flow cytometry was tested in HCT116 cells overexpressing POR (HCT116/POR). After exposure to the probes at 50 μM for 2 h, all four gave monodispersestained populations under anoxia (Supplementary Figure S1 at http://www.biochemj.org/bj/452/bj4520079add.htm). On the basis of the median fluorescence ( Figure 1B ), FSL-95 gave the highest intensity under anoxia, but this was incompletely inhibited by oxygen, with only a 3.5-fold decrease. FSL-76 showed an even weaker median fluorescence differential for anoxic cells (1.16-fold), whereas FSL-41 gave little signal in anoxic cells. The best balance of anoxic signal intensity and anoxic selectivity was achieved with FSL-61, which showed no detectable fluorescence under oxic conditions. FSL-61 activation was POR-dependent in these cells, giving similar median fluorescence intensity in parental HCT116 cells at 300 μM and HCT116/POR at 33 μM ( Figure 1C ). The marked anoxic selectivity of FSL-61 in HCT116/POR cells was confirmed over a wider range of concentrations, with a linear FSL-61 concentration dependence at 300 μM ( Figure 1D ). The linear fit overpredicted fluorescence at 1000 μM, suggesting possible saturation kinetics at very high concentrations. Using confocal microscopy, fluorescence was again selective for anoxia and appeared to be cytosolic with no evidence of subcellular localization ( Figure 1E ). Fluorescence was stably retained in the cells after successive centrifugation wash steps with ice-cold PBS (Supplementary Figure S2A at http://www.biochemj.org/bj/452/bj4520079add.htm), and was unchanged when samples were held in ice-cold medium for up to 2 h before flow cytometry (Supplementary Figure S2B ).
An important question is whether the fluorescent metabolite(s) were sufficiently well retained in cells during FSL-61 exposure at 37
• C to provide information about cellular heterogeneity of reductase expression. We therefore exposed mixed populations of HCT116/POR and parental HCT116 cells to FSL-61 and evaluated the distribution of fluorescence by flow cytometry (Figure 2) . The low-and high-fluorescence subpopulations could be readily distinguished, even after an incubation time of 3 h, with the proportion of the two peaks consistent with the input proportions of wild-type and POR cells. However, some increase in the median fluorescence intensity of the low-reductase population was evident in the presence of an excess of PORoverexpressing cells (Figure 2 ), indicating that some fluorescent metabolite transfer does occur under these conditions. 
Fluorescence properties of chemical and enzymatic reduction products of FSL-61
Before identifying the fluorescent metabolites of FSL-61 in cells, its chemical and enzymatic reduction products were characterized. Zinc dust reduction of FSL-61 in acetonitrile under anoxia, followed by dilution into aqueous buffer, demonstrated marked fluorescence with an excitation maximum of 360 nm and emission maximum of 460 nm, whereas the parent nitro compound was non-fluorescent under the same conditions (Supplementary Figure S3 at http://www.biochemj.org/bj/452/ bj4520079add.htm). Reverse-phase HPLC initially demonstrated a single polar UV-absorbing product, but MS evidence for both the hydroxylamine (m/z 249) and amine (m/z 233) in this peak led us to optimize the chromatography, eventually partially resolving two peaks ( Figure 3A ) at retention times of 3.7 min (compound 1) and 3.9 min (compound 2). Their identities were assigned as the hydroxylamine and amine on the basis of their distinctive UV spectra ( Figure 3B) ; for compound 2, the spectrum was identical with an authentic sample of the amine analogue of FSL-41 (Supplementary Figure S4A at http://www.biochemj.org/bj/452/ bj4520079add.htm). This assignment was supported further by ESI mass spectra ( Figure 3C Figure 3A) .
Enzymatic reduction of FSL-61 with purified human recombinant POR under anoxic conditions ( Figure 3D ) caused ∼ 78 % loss of FSL-61. This resulted in a single UV peak corresponding to the hydroxylamine (confirmed by UV and mass spectra, Supplementary Figures S4B and S4C) , with a very small fluorescent peak at a slightly longer retention time consistent with the amine (Figure 3D ). On the basis of the ratio of extracted ion counts of both products eluting at 3-4 min, and assuming the hydroxylamine and amine to have similar detection efficiencies by ESI, we estimate that the hydroxylamine/amine ratio was ∼ 90 under these conditions.
Characterization of FSL-61 metabolites in anoxic HCT116/POR cultures
To characterize the cellular metabolism of FSL-61, HCT116/POR cells were treated with FSL-61 under oxic and anoxic conditions for 0.5 and 3 h. Cell pellets (collected rapidly without trypsinization) and extracellular medium were analysed to assess the extent of intracellular entrapment of metabolites. UV chromatograms of cell pellets revealed a peak at 3.1 min (compound 3, Figure 4A ) which was present at lower levels in the extracellular medium ( Figure 4B) and not observed as a chemical reduction product of FSL-61 ( Figure 3) . The ESI mass spectrum of compound 3 showed a base peak at m/z 219 (Supplementary Figure S5 at http://www.biochemj.org/bj/452/bj4520079add.htm), consistent with the M + H + ion of the free acid resulting from hydrolysis of the amine ester (compound 2). Its UV spectrum (Supplementary Figure S5 ) was similar to that of compound 2, and thus consistent with this assignment. To confirm its identity, the acid analogue of FSL-61, compound 4, was chemically reduced with zinc dust. This provided the same product (by retention time, UV and mass spectrum; Supplementary Figure S5) , confirming the identity of compound 3 as the 6-amino acid metabolite ( Figure 4A) . A minor peak was also detected in cells ( Figure 4A ) and medium ( Figure 4B ) at retention time ∼ 15.5 min which corresponded to that of the authentic nitro acid compound 4, the assignment of which was confirmed by identity of UV and mass spectra (M + H + m/z 249, Supplementary Figure S5 ). Time-dependent changes in the relative concentration of these species show that FSL-61 hydrolyses progressively to the nonfluorescent nitro-acid (compound 4) which accumulates between 30 min and 3 h in both cells and medium ( Figure 4C ). In contrast, the initial fluorescent product, the 6-amino ester (compound 2), is seen at higher concentrations intracellularly than extracellularly at 30 min, but clearly diffuses into the extracellular medium by 3 h (Figure 4D ). The corresponding 6-amino acid (compound 3) is more highly retained in cells, as expected ( Figure 4E ). However, even for this second fluorescent product, some efflux into medium is evident by 3 h. The 6-hydroxylamine ester (compound 1) was also seen in cells after 30 min, but decreases after 3 h ( Figure 4F ). The inferred metabolic scheme ( Figure 5 ) is consistent with the time-dependent changes in the concentration of the metabolites (e.g. compound 1 concentration is highest at 30 min, compound 2 concentration is similar at both time points, and compound 3 is strongly elevated by 3 h), and is also consistent with the slow transfer of fluorescent metabolites from high POR-expressing cells as seen by flow cytometry (Figure 2 ). However, we cannot exclude the possibility that reduction of the nitro-acid (compound 4) also contributes to the formation of 3, although the putative hydroxylamine-acid intermediate was not detected.
Reductase profile of FSL-61
As a nitroaromatic compound, FSL-61 is potentially a substrate for reduction by oxidoreductases other than POR. To assess its reductase profile, we used flow cytometry to evaluate oxic and anoxic activation of FSL-61 by a panel of HCT116 cell lines over-expressing various enzymes known to be capable of nitroreduction ( Figure 6 ). The members of the diflavin reductase family (MTRR, NDOR1 and NOS2a, as well as POR) showed a highly significant increase (P < 0.001) in reduction of FSL-61 to its fluorescent metabolites compared with wild-type HCT116 cells. FDXR, an FAD-containing oxidoreductase which has been shown to be capable of reducing mitomycin C [31] , showed a smaller, but statistically significant, increase (P = 0.023) in FSL-61 median fluorescence compared with wild-type cells. In each of these cases, FSL-61 reduction was specific for anoxia, and the FSL-61 signal indicated homogenous reductase expression (results not shown). The two-electron reductases NQO1, NQO2 and AKR1C3, and the NADH-dependent reductase CYB5R3, did not increase median fluorescence compared with wild-type cells under either oxic or anoxic conditions. Incubation with the flavoprotein inhibitor DPI (100 μM) for 1 h before and during FSL-61 exposure resulted in the complete ablation of metabolism of FSL-61 in all of the reductase-overexpressing lines, as expected. DPI also completely inhibited FSL-61 activation in wild-type cells, suggesting that the bioreductive metabolism of this compound is mediated exclusively by flavoproteins.
FSL-61 as a predictive marker for hypoxic metabolism of PR-104A
The reductase profile of FSL-61 under anoxic conditions is similar to that for the bioreductive prodrug PR-104A in the same panel of reductase-overexpressing HCT116 cell lines under anoxia (POR>MTRR>NOS2a NDOR1>other reductases) [16] . This suggested that FSL-61 activation might be a predictive biomarker for the ability of human tumour cells to activate PR-104A to its cytotoxic metabolites (hydroxylamine PR-104H and amine PR-104M). To test this, we compared FSL-61 activation (by flow cytometry) with published information on formation of PR-104H and PR-104M from PR-104A from our laboratory [16] , using the same cell line stocks and experimental conditions, in a set of 22 human tumour cell lines under anoxia (Supplementary  Table S1 at http://www.biochemj.org/bj/452/bj4520079add.htm). The formation of PR-104A metabolites under oxic conditions was subtracted from the anoxic metabolites to exclude oxygeninsensitive activation of PR-104A by AKR1C3 [30] , given that AKR1C3 does not activate FSL-61 ( Figure 6 ). The five lines showing highest activation of FSL-61 (median fluorescence >600; H522, Panc-1, H1299, SiHa and Hep3B) were also fast metabolizers of PR-104A by anoxic (one-electron) reductases, whereas the lines with less capacity for FSL-61 activation were slow metabolizers of PR-104A. The correlation between FSL-61 and PR-104A activation (Figure 7 ) was statistically significant (P = 0.009), although weak by linear regression (R 2 = 0.293). This correlation was stronger (R 2 = 0.586) and highly significant (P < 0.001) when HCT8-Sa was excluded. We tested whether the slow metabolism of FSL-61 relative to PR-104A by anoxic HCT-8Sa cells reflects a difference in the FSL-61 metabolic pathway in this cell line (e.g. failure to reduce the hydroxylamine, compound 1, to the amine, compound 2, or failure of esterase activity to generate the cell-entrapped acid metabolites). However, the metabolite profile in HCT-8Sa and HCT116 cells were not significantly different (Supplementary Figure S6 at http://www.biochemj.org/bj/452/bj4520079add.htm).
DISCUSSION
In the present study, we have identified a simple 6-nitroquinolone carboxylic acid ester, FSL-61, as a fluorogenic probe for monitoring the enzymatic activity of POR and related one-electron reductases by microscopy or flow cytometry. FSL-61 displayed high hypoxic selectivity with no detectable activation under aerobic conditions; after subtracting the autofluorescence blank, the data of Figure 1(D) indicate an anoxic/oxic differential of ∼ 400-500-fold at 300-1000 μM FSL-61, which compares very favourably with other reported compounds using flow cytometry methods [32] [33] [34] [35] or plate reader assays [8, 12, 36, 37] .
Having established the ability of FSL-61 to detect heterogeneous POR expression in mixed cultures (Figure 2 ), we undertook a detailed characterization of its metabolites and reductase specificity. Chemical reduction of FSL-61 generated the 6-hydroxylamine (compound 1) and 6-amine (compound 2); partial chromatographic resolution showed the amine to be much more intensely fluorescent than the hydroxylamine (Figures 3A-3C ), reflecting the weaker electron donating character of the hydroxylamino than amine moiety; this finding is consequent with earlier observations suggesting that hydroxylamines from nitroacridines and nitronaphthalimides are much less fluorescent than the corresponding amines [6, 14] . Enzymatic reduction with purified human POR generated the 6-hydroxylamine, with only a trace of the fluorescent amine ( Figure 3D) ; reduction only to the hydroxylamine by POR is also seen with other nitroaromatics [38, 39] . In contrast, a recent evaluation of the reduction of 6-nitroquinoline by POR in vitro [13] identified an azoxy-helicene derivative as the major fluorescent product. We checked for the formation of corresponding products from FSL-61, but found no evidence of the corresponding helicene (or other azoxy derivatives) species by LC-MS.
The metabolite profile from FSL-61 in HCT116/POR cells was distinctly different from that for purified POR, and was consistent with the metabolic scheme shown in Figure 5 . Intracellular hydroxylamine (compound 1) was detectable as an intermediate by MS, but the major reduced metabolites were the amine-ester (compound 2) and the corresponding free acid (compound 3), both of which were highly fluorescent. Thus the initial POR reduction product, the hydroxylamine-ester (compound 1), is presumably a substrate for further reduction in HCT116 cells by other enzymes such as the CYB5R3 in concert with cytochrome b 5 [40] . The hydrolysis product of unreduced FSL-61 was also detected (nitroacid, compound 4), but the hydroxylamine-acid was not seen by MS, suggesting that compound 3 may derive primarily from hydrolysis of compound 2 rather than reduction of compound 4. Evaluation of the metabolite profile in cells and extracellular medium after 30 min and 3 h (Figure 4) showed that the amineester (compound 2) was less well entrapped in the cells than the amine-acid (compound 3). Hence the presence of the acid side chain increased cellular entrapment of the amine-acid (compound 3) as expected. Thus the transfer of fluorescent metabolites from cells with high POR activity to cells with low activity (Figure 2 ) is likely to be mediated primarily via diffusion of the amine-ester (compound 2), and through the hydroxylamine-ester (compound 1) which would be reduced further in low-POR cells, with lesser contributions from the acid metabolites.
Although FSL-61 is clearly a substrate for POR, it is also important to establish whether it is specific for POR or might act as a more generic reporter of one-electron reductase activity. Using a previously characterized panel of HCT116 cell lines that overexpress specific oxidoreductases [16] , we have shown that FSL-61 is also activated under anoxia by diflavin reductases orthologous to POR (MTRR, NDOR1 and NOS2A) as well as to the unrelated [31] flavoenzyme FDXR ( Figure 6 ). Given that four of five candidate one-electron reductases we tested significantly activated FSL-61, it is unlikely that all of the FSL-61 reductases have been identified in this small panel. Importantly, for the use of FSL-61 as a hypoxia-specific probe, the known human oxygen-insensitive nitroreductases (NQO1, NQO2 and AKR1C3) did not activate FSL-61 ( Figure 6 ).
The similarity of one-electron reductase profile for FSL-61 to that for PR-104A in the same cell lines led us to ask whether FSL-61 reduction would correlate with PR-104A reduction in a diverse panel of human tumour cell lines. We investigated a panel of 23 cell lines for which PR-104A reduction has been reported recently [16] ; changes in flow cytometry scatter parameters indicated FSL-61 was toxic in one of these lines (HepG2), which was excluded from further analysis. For the remaining 22 cell lines, the relationship was statistically significant, and was strengthened further when a clear outlier (HCT8-Sa) was excluded. The anomalously high PR-104A reduction in HCT8Sa relative to FSL-61 metabolism could reflect differences in the one-electron reductase profile of FSL-61 and PR-104A (beyond the limited number of reductases investigated in the present study). Alternatively, cell line differences in activity of other enzymes such as esterases that assist entrapment of the amine acid (compound 3) or reductases that convert the non-fluorescent hydroxylamine into amine might influence the FSL-61 signal, although the similar FSL-61 metabolite profile in HCT8-Sa and HCT116 cells argues against the latter interpretation. Further investigation is needed to clarify this apparent difference between PR-104A and FSL-61 metabolism. However, to our knowledge, FSL-61 is the only fluorogenic hypoxia probe for which the metabolic pathway in cells and reductase profile is (at least partially) defined. Furthermore, to our knowledge, it is the only such probe to combine very high hypoxic selectivity, insensitivity to activation by two-electron (oxygen-insensitive) human nitroreductases and sufficient cellular retention of fluorescent metabolites to enable interrogation of reductase activity (and hypoxia) at the single-cell level. Given the simplicity of the assay, we anticipate that this new probe will be useful for monitoring hypoxia in tissue culture studies, for characterizing the activity of one-electron reductases in hypoxic cells and potentially as a predictive biomarker for activation of PR-104A and other hypoxia-selective bioreductive prodrugs in clinical trials. An authentic sample of the hydrolysis product from FSL-61 (compound 4) eluted with a retention time (RT) of 13.2 min, and with an absorption spectrum consistent with the 6-nitroquinolone chromophore and an m/z (M + H + ) of 249. The corresponding zinc dust reduction product eluted at 3.1 min with an m/z of 219 (M + H + ) consistent with the corresponding amine (compound 3). Cmpd, compound; mAU, milli-absorbance units.
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Figure S6 Comparison of FSL-61 metabolites in HCT116 and HCT8-Sa
HCT116 and HCT8-Sa samples were treated with 300 μM for 3 h and samples were harvested as outlined in the Experimental section of the main paper. The measured concentration of (A) FSL-61 and (B) compound 4 were calculated from standard curves using authentic compound. The concentrations of (C) compound 2 and (D) compound 3 were estimated using the standard curves of FSL-61 and compound 4 respectively. Results are means + − range from two experiments. Cmpd, compound; ND, not determined.
